Natural history of compensated and decompensated HCV-related cirrhosis in HIV-infected patients : a prospective multicentre studyGIRON-GONZALEZ, José A; BRUN, Francisco; TERRON, Alberto et al.Antiviral therapy (London). 2007, Vol 12, Num 6, pp 899-907, issn 1359-6535, 9 p.Article

Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis CMIRA, José A; MACIAS, Juan; GOMEZ-MATEOS, Jesus et al.Journal of antimicrobial chemotherapy (Print). 2006, Vol 58, Num 1, pp 140-146, issn 0305-7453, 7 p.Article

Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virusMARTINEZ-SIERRA, Carmen; ARIZCORRETA, Ana; DIAZ, Fernando et al.Clinical infectious diseases. 2003, Vol 36, Num 4, pp 491-498, issn 1058-4838, 8 p.Article

Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/ Hepatitis C Virus―Coinfected Patients With Compensated CirrhosisMIRA, José A; RIVERO-JUAREZ, Antonio; GEA, Isabel et al.Clinical infectious diseases. 2013, Vol 56, Num 11, pp 1646-1653, issn 1058-4838, 8 p.Article

HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosisPINEDA, Juan A; ROMERO-GOMEZ, Manuel; NAVARRO, José M et al.Hepatology (Baltimore, Md.). 2005, Vol 41, Num 4, pp 779-789, issn 0270-9139, 11 p.Article

Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: Prospective analysis of 404 individualsGIRON-GONZALEZ, José A; GARCIA DEL RIO, Enrique; RODRIGUEZ, Carmen et al.Journal of rheumatology. 2004, Vol 31, Num 8, pp 1560-1567, issn 0315-162X, 8 p.Article

Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-α blockade in patients with rheumatoid arthritisMACIAS, Inmaculada; GARCIA-PEREZ, Sergio; RUIZ-TUDELA, Mar et al.Journal of rheumatology. 2005, Vol 32, Num 11, pp 2102-2108, issn 0315-162X, 7 p.Article

Dilutional hyponatremia in patients with cirrhosis and ascitesPORCEL, Almudena; DIAZ, Fernando; RENDON, Paloma et al.Archives of internal medicine (1960). 2002, Vol 162, Num 3, pp 323-328, issn 0003-9926Article

Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitisRODRIGUEZ-RAMOS, Claudio; GALAN, Fatima; DIAZ, Fernando et al.Digestive diseases and sciences. 2001, Vol 46, Num 8, pp 1668-1676, issn 0163-2116Article

Natural History of Compensated Hepatitis C Virus-Related Cirrhosis in HIV-Infected PatientsPINEDA, Juan A; AGUILAR-GUISADO, Manuela; MERCHANTE, Nicolás et al.Clinical infectious diseases. 2009, Vol 49, Num 8, pp 1274-1282, issn 1058-4838, 9 p.Article

Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimenCRESPO, Manuel; MIRA, José A; MERINO, Dolores et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 62, Num 4, pp 793-796, issn 0305-7453, 4 p.Article

Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver diseaseMERCHANTE, Nicolas; GIRON-GONZALEZ, José A; MACIAS, Juan et al.AIDS (London). 2006, Vol 20, Num 1, pp 49-57, issn 0269-9370, 9 p.Article

Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosisGARCIA-GARCIA, José A; ROMERO-GOMEZ, Manuel; MARTIN-VIVALDI, Javier et al.AIDS research and human retroviruses. 2006, Vol 22, Num 12, pp 1236-1241, issn 0889-2229, 6 p.Article

Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patientsMIRA, Jasé A; VALERA-BESTARD, Barbara; LOPEZ-CORTES, Luis F et al.Antiviral therapy (London). 2007, Vol 12, Num 4, pp 523-529, issn 1359-6535, 7 p.Article

Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patientsPINEDA, Juan A; MIRA, José A; GARCIA-GARCIA, José A et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 60, Num 6, pp 1347-1354, issn 0305-7453, 8 p.Article

Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patientsMIRA, José A; LOPEZ-CORTES, Luis F; VALERA-BESTARD, Barbara et al.Antiviral therapy (London). 2007, Vol 12, Num 8, pp 1225-1235, issn 1359-6535, 11 p.Article

Hepatic Steatosis and Steatohepatitis in Human Immunodeficiency Virus/Hepatitis C Virus―Coinfected PatientsMACIAS, Juan; BERENGUER, Juan; MIRALLES, Pilar et al.Hepatology (Baltimore, Md.). 2012, Vol 56, Num 4, pp 1261-1270, issn 0270-9139, 10 p.Article

Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus―Coinfected Patients With Compensated Liver CirrhosisMIRA, Jose A; GARCIA-REY, Silvia; MACIAS, Juan et al.Clinical infectious diseases. 2012, Vol 55, Num 12, pp 1719-1726, issn 1058-4838, 8 p.Article

Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patientsMIRA, José A; RIVERO, Antonio; OMAR, Mohamed et al.AIDS (London). 2012, Vol 26, Num 13, pp 1721-1724, issn 0269-9370, 4 p.Article